2009
DOI: 10.1093/humrep/den425
|View full text |Cite
|
Sign up to set email alerts
|

A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion

Abstract: Simultaneous use of mifepristone and misoprostol for second trimester medical abortion is not as effective as the regimen using a 36-38 h dosing interval.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
15
1
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 13 publications
3
15
1
1
Order By: Relevance
“…One RCT reported an increase in chills and fever with mifepristone and immediate misoprostol when compared to a 36- to 38-hour interval [12]. All published studies reported no increase in adverse events, which is in agreement with our findings [13,14,15,16,17].…”
Section: Discussionsupporting
confidence: 91%
See 4 more Smart Citations
“…One RCT reported an increase in chills and fever with mifepristone and immediate misoprostol when compared to a 36- to 38-hour interval [12]. All published studies reported no increase in adverse events, which is in agreement with our findings [13,14,15,16,17].…”
Section: Discussionsupporting
confidence: 91%
“…These intervals are similar to our standard regimen but are significantly shorter than the 16 h in our short regimen cohort, although the mifepristone-to-misoprostol interval of 12 h in the short regimen cohort is considerably less than that in the existing literature. Four RCTs reported percentage expulsion at 12 h post-misoprostol for mifepristone-to-misoprostol intervals <36 h, ranging from 73 to 82% compared to 36.3% in our short regimen cohort [12,13,14,16], although again the mifepristone-to-misoprostol intervals were greater than in our short regimen. Information regarding expulsion at 24 h was provided by 5 of the 6 studies examined and ranged from 91 to 98% [12,14,15,16,17], compared to 80% in our short and 91% in our standard regimen cohorts, respectively.…”
Section: Discussioncontrasting
confidence: 63%
See 3 more Smart Citations